Suzlon secures 170.1 MW wind power project from AMPIN Energy in Andhra Pradesh
This partnership is a major boost to India's renewable energy goals and the Make in India initiative, showcasing the growing synergy between local manufacturing and clean power deployment. Suzlon and AMPIN's continued collaboration reflects a shared vision of accelerating the nation's move to a low-carbon, energy-secure future through innovative, locally produced wind energy solutions.
Under the terms of the agreement, Suzlon will deliver 54 of its cutting-edge S144 wind turbine generators (WTGs) , each with a capacity of 3.15 MW. The turbines will be mounted on Hybrid Lattice Towers (HLT) , known for their superior efficiency and cost-effectiveness.
The project scope includes comprehensive execution—from equipment supply and installation to commissioning and long-term operations and maintenance services—ensuring end-to-end support for the clean energy venture.
JP Chalasani, Chief Executive Officer, Suzlon Group, said, 'India's decarbonization journey will be won or lost at the distribution level. DISCOMs are the critical link between renewable energy generation and everyday consumption—from industries to households. To empower them with reliable, cost‐efficient clean power is not just a goal—it's a national imperative. Together, we're proving that clean energy isn't just viable—it's vital, scalable, and transformative for the power sector.'
This strategic partnership not only highlights the scalability of renewable energy infrastructure in India but also underpins efforts to make green power more accessible and affordable for industries across the country.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
8 hours ago
- Business Upturn
Tilaknagar Industries to acquire Imperial Blue business division from Pernod Ricard for Rs 4,150 crore
Tilaknagar Industries (TI), a key player in India's alcoholic beverages space, is making headlines with a landmark acquisition. The company has signed a definitive agreement to buy the Imperial Blue whisky business division from Pernod Ricard India for approximately ₹4,150 crore (€412.6 million), through a slump sale deal. A part of the payment—€28 million (around ₹282 crore)—will be deferred and paid four years after the deal closes. This acquisition marks TI's biggest move yet, helping the company enter the whisky market in a big way. Imperial Blue, the third-largest whisky brand in India by volume, sold 22.4 million 9-litre cases in FY25 and generated revenue of ₹3,067 crore. The deal also includes two owned manufacturing units and access to several co-manufacturing partners across India. Best known for its popular Mansion House Brandy, Tilaknagar Industries now aims to scale its presence across both the brandy and whisky segments, with a combined annual volume of 34 million cases. The acquisition fast-tracks TI's goal of becoming a major whisky player and expanding its distribution footprint pan-India. TI will use a mix of debt and equity to fund the acquisition, which is subject to CCI approval and is expected to close in six months. Deutsche Bank and Avendus Capital advised the deal, with legal and diligence support from Crawford Bayley, W.S. Kane, and Deloitte. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
11 hours ago
- Business Upturn
BEML bags defence order worth Rs 293.82 crore for supply of HMV 6×6 vehicles
BEML Limited has announced that it has secured a fresh order worth approximately ₹293.82 crore from the Ministry of Defence for the supply of High Mobility Vehicles (HMV) 6X6. The disclosure was made pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015. This new contract strengthens BEML's position as a key defence equipment supplier, highlighting its capability to deliver advanced, indigenous mobility solutions for the armed forces under the government's 'Make in India' initiative. Notably, on July 18, BEML had also announced a separate order worth ₹185.65 crore from the Ministry of Defence (E-in-C) for the supply of bulldozers. That earlier order, which was made in the normal course of business, further deepened the company's long-standing relationship with the Ministry and added to its already strong defence-focused order pipeline. While the bulldozer order is unrelated to the latest HMV contract, both reinforce BEML's critical role in supporting India's defence infrastructure through consistent and high-quality equipment deliveries. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
13 hours ago
- Business Upturn
Dr Reddy's Laboratories Q1 Results: Revenue jumps 11.4% YoY to Rs 8,545 crore, net profit marginally up
Dr. Reddy's Laboratories kicked off the fiscal year on a solid note, posting its Q1 FY26 results with a healthy revenue increase but a slight dip in margins. The Hyderabad-based pharma giant reported a net profit of ₹1,417.8 crore, up 1.8% from ₹1,392 crore in the same quarter last year. Revenue for the quarter stood at ₹8,545 crore, marking a strong 11.4% year-on-year (YoY) growth compared to ₹7,672.7 crore in Q1 FY25. The company's operating performance also showed improvement, with EBITDA rising 5% YoY to ₹2,278 crore, up from ₹2,160 crore in the previous year. However, the EBITDA margin contracted to 26.7%, compared to 28.2% in Q1 FY25, indicating cost pressures or product mix changes impacting profitability. One key weak spot was in the North American market, where sales declined by 11% YoY to ₹3,410 crore, down from ₹3,846 crore. This drop may reflect pricing pressure and competitive dynamics in the generics space. In the meantime, Dr Reddy's Laboratories shares closed at ₹1,248.00 today, slightly higher than the opening price of ₹1,240.20. The stock touched an intraday high of ₹1,252.10 and a low of ₹1,231.00 during the session. Over the past year, the stock has seen a 52-week high of ₹1,421.49 and a low of ₹1,020.00. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
